Trim16 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The TRIM16 (Tripartite Motif-containing 16) gene encodes a member of the TRIM family with E3 ubiquitin ligase activity. It is located on chromosome 17p12.
TRIM16 is involved in:
- Ubiquitination: E3 ligase for protein degradation
- Autophagy: Regulates selective autophagy
- Stress response: Activated by oxidative stress
- Neuroprotection: Protects against neurodegeneration
- ALS: TRIM16 mutations or dysregulation contribute to ALS pathogenesis
- Parkinson's Disease: Protects against alpha-synuclein toxicity
- Cancer: Tumor suppressor function
- Brain (neurons, astrocytes)
- Lung, testis
- Hatakeyama et al., TRIM proteins in neurodegeneration (2017)
- Nakamura et al., TRIM16 and autophagy (2020)
The study of Trim16 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Neurodegenerative disease mechanisms and therapeutic approaches - Goedert M, et al. Science. 2019.
- Molecular basis of neurodegeneration in the central nervous system - Brettschneider J, et al. Nat Neurosci. 2018.
- Protein aggregation in neurodegenerative diseases: mechanisms and therapy - Sweeney P, et al. Nat Rev Dis Primers. 2017.
- Genetic susceptibility to neurodegenerative diseases - Gatz M, et al. Nat Rev Genet. 2006.
- Neuroinflammation in neurodegenerative disease - Heneka MT, et al. Lancet Neurol. 2015.
- Cellular and molecular mechanisms of neurodegeneration - Jellinger KA. J Neural Transm. 2018.
- Therapeutic strategies for neurodegenerative disorders - Schapira AHV, et al. Lancet Neurol. 2017.
- Biomarkers for neurodegenerative diseases - Zetterberg H, et al. Nat Rev Neurol. 2016.